AstraZeneca
AZN
#47
Rank
HK$2.208 T
Marketcap
HK$712.19
Share price
0.21%
Change (1 day)
40.45%
Change (1 year)

EPS for AstraZeneca (AZN)

EPS in 2025 (TTM): HK$23.66

According to AstraZeneca's latest financial reports the company's current EPS (TTM) is HK$23.61. In 2024 the company made an earnings per share (EPS) of HK$17.66 an increase over its 2023 EPS that were of HK$14.94.

EPS history for AstraZeneca from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)HK$23.6633.99%
2024HK$17.6618.23%
2023HK$14.9481.13%
2022HK$8.25631.03%
2021HK$1.13-88.11%
2020HK$9.49136.89%
2019HK$4.01-39.41%
2018HK$6.61-28.27%
2017HK$9.22-14.37%
2016HK$10.7724.11%
2015HK$8.67127.55%
2014HK$3.81-51.96%
2013HK$7.93-58.95%
2012HK$19.33-32.2%
2011HK$28.51

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Bristol-Myers Squibb
BMY
HK$23.10-2.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
HK$13.38-43.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$59.07 150.21%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
HK$27.97 18.48%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sanofi
SNY
HK$28.83 22.10%๐Ÿ‡ซ๐Ÿ‡ท France
Eli Lilly
LLY
HK$159.62 576.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
HK$81.21 243.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
HK$62.68 165.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
HK$85.49 262.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$57.26 142.50%๐Ÿ‡จ๐Ÿ‡ญ Switzerland